Radicava ORS 735 MG per 35 ML Oral Suspension
- RxCUI
- 2602122
- RxNorm name
- Radicava ORS 735 MG per 35 ML Oral Suspension
- Display name
- Radicava ORS 735 MG per 35 ML Oral Suspension
- Full name
- Radicava ORS 735 MG per 35 ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RADICAVA ORS | EDARAVONE | Shionogi Inc. | 0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11 | 2026-05-05 | Warnings, Adverse reactions | 2602122 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11 | Radicava ORS 21 MG/mL Oral Suspension [PSN] · edaravone 21 MG/ML Oral Suspension [Radicava] [SBD] · Radicava ORS 1050 MG per 50 ML Oral Suspension [SY] · Radicava ORS 21 MG/ML Oral Suspension [SY] · Radicava ORS 735 MG per 35 ML Oral Suspension [SY] | 5 | 29 | These highlights do not include all the information needed to use RADICAVA or RADICAVA ORS safely and effectively. See full prescribing information for RADICAVA or RADICAVA ORS. RADICAVA ® (edaravone) injection, for intravenous use RADICAVA ORS ® (edaravone) oral suspension Initial U.S. Approval: 2017 | 20260505 |